The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon

Transplantation

Volumn 82, Issue 12, 2006, Pages 1667-1672

  Sharif, Adnan ^a   Moore, Richard H ^a   Baboolal, Keshwar ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Glucose metabolism; Kidney transplant; NODAT; Oral glucose tolerance test

Indexed keywords

GLUCOSE;

ADULT; AGED; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRAFT RECIPIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

ADULT; AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK;

EID: 33845923313     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000250924.99855.42     Document Type: Conference Paper

References (44)

1. Woodward RS, Schnitzler MA, Baty J, et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 2003; 3(5): 590.
2. Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59(2): 732.
3. Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62(4): 1440.
4. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3(2): 178.
5. Tutone VK, Mark PB, Revanur V, et al. Random blood glucose measurements and survival in nondiabetic renal transplant recipients. Transplant Proc 2004; 36(10): 3006.
6. Markell M. New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management. Am J Kidney Dis 2004; 43(6): 953.
7. Montori VM, Basu A, Erwin PJ, et al. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002; 25(3): 583.
8. Krentz AJ, Wheeler DC. New-onset diabetes after transplantation: a threat to graft and patient survival. Lancet 2005; 365(9460): 640.
9. Wilkinson A, Davidson J, Dotta F, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005; 19(3): 291.
10. Kasiske BL. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 2001; 72(6 Suppl): S5.
11. Schnell O. The links between diabetes and cardiovascular disease. J Interv Cardiol 2005; 18(6): 413.
12. Ducloux D, Kazory A, Chalopin JM. Predicting coronary heart disease in renal transplant recipients: a prospective study. Kidney Int 2004; 66(1): 441.
13. Aakhus S, Dahl K, Wideroe TE. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant 1999; 14(3): 648.
14. de Mattos AM, Prather J, Olyaei AJ, et al. Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int 2006; 70(4): 757.
15. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Transplantation 2003; 75(10 Suppl): SS3-24.
16. Davidson JA, Wilkinson A. New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: an endocrinologist's view. Diabetes Care 2004; 27(3): 805.
17. Piche ME, Despres JP, Pascot A, et al. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk? Diabet Med 2004; 21(7): 730.
18. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19(9): 708.
19. Heldgaard PE, Olivarius Nde F, Hindsberger C, Henriksen JE. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease. Diabet Med 2004; 21(4): 363.
20. Ekstrand AV, Eriksson JG, Gronhagen-Riska C, et al. Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 1992; 53(3): 563.
21. Nam JH, Mun JI, Kim SI, et al. Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 2001; 71(10): 1417.
22. Cheng C, Kushner H, Falkner BE. The utility of fasting glucose for detection of prediabetes. Metabolism 2006; 55(4): 434.
23. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe. Diabetologia 1999; 42(6): 647.
24. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 Suppl 1: S5-20.
25. Standards of medical care in diabetes-2006. Diabetes Care 2006; 29 Suppl 1: S4-42.
26. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999; 354(9179): 617.
27. Leiter LA, Ceriello A, Davidson JA, et al. Postprandial glucose regulation: new data and new implications. Clin Ther 2005; 27 Suppl B: S42.
28. Sorkin JD, Muller DC, Fleg JL, Andres R. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 2005; 28(11): 2626.
29. Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999; 22(6): 920.
30. Zhang YF, Hong J, ZhanWW,et al. Hyperglycaemia after glucose loading is a major predictor of preclinical atherosclerosis in nondiabetic subjects. Clin Endocrinol (Oxf) 2006; 64(2): 153.
31. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344(18): 1343.
32. Baltar J, Ortega T, Ortega F, et al. Posttransplantation diabetes mellitus: prevalence and risk factors. Transplant Proc 2005; 37(9): 3817.
33. Foo SM, Wong HS, Morad Z. Risk factors and incidence of posttransplant diabetes mellitus in renal transplant recipients. Transplant Proc 2004; 36(7): 2139.
34. Midtvedt K, Hartmann A, Hjelmesaeth J, et al. Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients. Nephrol Dial Transplant 1998; 13(2): 427.
35. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23(5): 469.
36. Marin M, Renoult E, Bondor CI, Kessler M. Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience. Transplant Proc 2005; 37(4): 1851.
37. Santaguida PL, Balion C, Hunt D, et al. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Evid Rep Technol Assess (Summ) 2005; (128): 1.
38. Hagen M, Hjelmesaeth J, Jenssen T, et al. A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant 2003; 18(10): 2154.
39. Borch-Johnsen K. IGT and IFG. Time for revision? Diabet Med 2002; 19(9): 707.
40. Meisinger C, Wolke G, Brasche S, et al. Postload Plasma Glucose and 30-Year Mortality Among Nondiabetic Middle-Aged Men From the General Population: The ERFORT Study. Ann Epidemiol 2006; 16(7): 534.
41. Shaw JE, Hodge AM, de Courten M, et al. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999; 42(9): 1050.
42. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20(4): 537.
43. Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 1999; 48(11): 2197.
44. Davies MJ, Raymond NT, Day JL, et al. Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med 2000; 17(6): 433.